Highlights
- The nation's medicine regulator on Saturday granted provisional approval to the Spikevax MODERNA jab for 12- to 17-year-olds, after it was previously given a green light for adults
- Parents are anxiously calculating the risk for their kids, as the Delta variant leads to a surge of new cases, including in children and teenagers.
- A growing number of teens are seeing the vaccine as a key to returning to their lives